Based on this, a prognostic model related to KRAS mutation was established to quantify individualized KRAS-related patterns in colon cancer patients, and to predict prognosis and personal response to drugs and therapies commonly used in clinical practice. The gene discussed is KRAS; the disease is malignant colon neoplasm.